0.9999
Precedente Chiudi:
$0.9893
Aprire:
$1
Volume 24 ore:
380.56K
Relative Volume:
0.44
Capitalizzazione di mercato:
$184.42M
Reddito:
-
Utile/perdita netta:
$52.50M
Rapporto P/E:
34.36
EPS:
0.0291
Flusso di cassa netto:
$-4.13M
1 W Prestazione:
-5.67%
1M Prestazione:
-18.04%
6M Prestazione:
-32.89%
1 anno Prestazione:
+61.53%
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Nome
Tevogen Bio Holdings Inc
Settore
Industria
Telefono
646-807-8832
Indirizzo
15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN
Confronta TVGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
TVGN
Tevogen Bio Holdings Inc
|
0.9999 | 191.62M | 0 | 52.50M | -4.13M | 0.0291 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-04 | Iniziato | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Borsa (TVGN) Ultime notizie
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders - GlobeNewswire
Tevogen's Major AI Push: CEO Reveals 74% Insider Stake and Microsoft Partnership in Growth Strategy - Stock Titan
Tevogen Bio stock rises amid $1 million grant funding By Investing.com - Investing.com Nigeria
Tevogen Bio stock rises amid $1 million grant funding - Investing.com
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion - GlobeNewswire
AI Drug Discovery Breakthrough: Tevogen Bio Receives Million-Dollar Grant to Transform Medicine Development - Stock Titan
How strong is Tevogen Bio Holdings Inc. company’s balance sheetAI Powered Tips With High Returns - jammulinksnews.com
Does Tevogen Bio Holdings Inc. stock perform well during market downturnsFree Stock Watchlist For Fast Growth - jammulinksnews.com
What are Tevogen Bio Holdings Inc. Equity Warrant company’s key revenue driversLow Risk Alerts Backed By Experts - jammulinksnews.com
Why did TVGN's Q4 2021 EPS show no surprise? - AInvest
Tevogen executives and directors own over 74% of company stock - Investing.com Australia
Tevogen executives and directors own over 74% of company stock By Investing.com - Investing.com Nigeria
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision - GlobeNewswire
Volume Profile Shows Strong Base for Tevogen Bio Holdings Inc.Weekly Watchlist of High Movers Released - metal.it
Tevogen Bio Holdings Inc. May Be Forming Higher Low — Chartwatchers AlertWatchlist for Low Risk High Return Stocks Updated - metal.it
Is Tevogen Bio Holdings Inc. Equity Warrant a growth stock or a value stockFree Stock Insights From AI Tools - jammulinksnews.com
What makes Tevogen Bio Holdings Inc. stock price move sharplyEntry Alert Based on Volume Spikes Detected - metal.it
Key External Factors That Drive Tevogen Bio Holdings Inc. Equity Warrant Stock Price MovementsNews Based Entry Opportunity Alerts Detected - metal.it
Published on: 2025-07-29 02:08:01 - metal.it
Tevogen Bio Holdings Inc. shares rise 1.85% after-hours after welcoming U.S. AI Action Plan. - AInvest
Why is Tevogen Bio Holdings Inc. stock attracting strong analyst attentionWealth Building Watchlist For Every Investor - jammulinksnews.com
Published on: 2025-07-28 21:09:55 - metal.it
Tevogen.AI Applauds U.S. Government's AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare - Investing News Network
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare - The Globe and Mail
Tevogen.AI Applauds U.S. Government’s AI Action Plan; - GlobeNewswire
Tevogen Teams Up with Microsoft to Transform Drug Development: New AI Platform Saves Billions in Research Costs - Stock Titan
Is Tevogen Bio Holdings Inc. stock overvalued or undervaluedExceptional profit margins - jammulinksnews.com
Does Tevogen Bio Holdings Inc. Equity Warrant stock perform well during market downturnsCapitalize on momentum-driven opportunities - jammulinksnews.com
What are Tevogen Bio Holdings Inc. company’s key revenue driversBuild a winning investment strategy - jammulinksnews.com
What institutional investors are buying Tevogen Bio Holdings Inc. stockExplosive wealth accumulation - jammulinksnews.com
What makes Tevogen Bio Holdings Inc. Equity Warrant stock price move sharplyCapitalize on emerging industry trends - jammulinksnews.com
How many analysts rate Tevogen Bio Holdings Inc. as a “Buy”Superior profit margins - jammulinksnews.com
Is it the right time to buy Tevogen Bio Holdings Inc. Equity Warrant stockInvest confidently with proven investment plans - jammulinksnews.com
What is the risk reward ratio of investing in Tevogen Bio Holdings Inc. Equity Warrant stockBuild wealth steadily with expert advice - jammulinksnews.com
What is the dividend policy of Tevogen Bio Holdings Inc. stockUnlock powerful stock screening techniques - jammulinksnews.com
Is Tevogen Bio Holdings Inc. Equity Warrant stock overvalued or undervaluedBreakthrough investment results - jammulinksnews.com
What is Tevogen Bio Holdings Inc. company’s growth strategyBreakout portfolio performance - jammulinksnews.com
When is Tevogen Bio Holdings Inc. stock expected to show significant growthTremendous return on equity - jammulinksnews.com
What is the dividend policy of Tevogen Bio Holdings Inc. Equity Warrant stockPowerful growth strategies - jammulinksnews.com
Published on: 2025-07-27 22:07:15 - jammulinksnews.com
How does Tevogen Bio Holdings Inc. compare to its industry peersFree Stock Selection - jammulinksnews.com
Tevogen Bio Holdings Inc Azioni (TVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):